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Background: Despite the improvement in the care management, women cancer patients who are still in employment
find themselves for the most part obliged to stop working while they are having treatment. Their return-to-work
probability is impacted by numerous psychosocial factors. The objective is to describe the development and the content
of an intervention aimed to facilitate the return to work of female breast cancer patients and in particular the women in
the most precarious situations through early active individualised psychosocial support (APAPI).
Methods: The intervention proposed is made up of 4 interviews with a psychologist at the hospital, distributed over the
year according to the diagnosis and conducted on the same day as a conventional follow-up consultation, then a
consultation with a specialist job retention physician. We expect, in the first instance, that this intervention will reduce
the social inequalities of the return-to-work rate at 12 months. The EPICES score will enable the population to be broken
down according to the level of social precariousness. The other expected results are the reduction of the social inequalities
in the quality of the return to work at 18 and 24 months and the disparities between the individual and collective
resources of the patients. This intervention is assessed in the context of a controlled and randomised multi-centre study.
The patients eligible are women aged between 18 and 55 years with a unilateral breast cancer with local extension
exclusively, having received surgery followed by adjuvant chemotherapy, in employment at the time of the diagnosis and
dealt with by one of the 2 investigating centres.
Discussion: It is essential to assess this type of intervention before envisaging its generalisation. The study set in place will
enable us to measure the impact of this intervention aiming to facilitate the return to work of breast cancer patients, in
particular for those who suffer from social fragility, compared with the standard care.
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With approximately 53,000 estimated new breast cancer
cases in 2011, breast cancer is top of the list of cancers
affecting women in France. The improvement in the care
therapy and earlier diagnosis are increasing the probability
of curing cancer and the 5-year survival rate is above 80%
between 15 and 64 years [1]. Even if breast cancer patients
have a lower probability of having a job than women in* Correspondence: clemence.vidor@univ-lille3.fr
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unless otherwise stated.the general population of the same age [2-4], breast cancer
often affects working women. The direct consequences of
the occurrence of the disease for most of them are the
need to take sick leave and the consequent significant loss
of earnings [5,6]. Whereas the duration of the sick leave
for these women is longer than for those suffering from
another type of cancer, the return-to-work rate is higher
[7,8]. However, one year after the first surgery, a female
breast cancer patient has almost 3 times as much risk of
no longer working as a woman in the general population
(23% vs. 9%) [4].
Return to work is a major issue and frequently affects
the quality of life, the financial security, the restoring oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[9,10]. According to the studies, the return-to-work rates
10 months after the diagnosis vary between 56% and 91%
[7,11]. In addition to the factors linked to the treatment
and the disease, return to work is impacted by certain
psychosocial characteristics. Thus, having a poor level of
education, working part-time or experiencing job-linked
difficulties (e.g. poor support from colleagues, a big phys-
ical and/or psychological workload) accentuate the reper-
cussions of the disease on job retention and their return
to work [9,10]. This is why special attention must be paid
to the role of the social inequalities in the occupational re-
habilitation and reintegration of these women.
In order to mitigate these difficulties and reduce these
social inequalities, Amir and Brocky [12] recommend the
inclusion as early as possible by the cancer care teams of
the return-to-work issue in the course of therapy. The im-
proving of the communication between the various health
players, in particular between the general practitioner (GP)
and the occupational physician, is also an avenue for inter-
vention to be developed in order to promote a return to
work [13]. Several intervention studies concerning the
inclusion of actions designed to facilitate return to work
in the course of cancer care have been conducted in re-
cent years. However, through a review of the literature,
Tamminga et al. [3] come to the finding that most of
these interventions do not aim in the first instance to
improve the return to work, but rather the quality of life
and/or the general physical and psychological function-
ing. Furthermore, these interventions have not for the
most part been the subject of randomised trials with a
control group, which limits the attribution of the return
to work to the intervention [3,14].
Owing to the impact of the factors influencing the return
to work, the resultant inequalities and the interventions
already conducted, we propose an intervention designed to
facilitate the occupational rehabilitation of female breast
cancer patients. An early active individualised psychosocial
support (APAPI) would enable, in our opinion, help to be
provided for the patients facing the greatest social and psy-
chological difficulties and so limit the consequences of
their disease on their work and generally speaking improve
their quality of life. The objective here is to describe 1) the
development and the content of our intervention, 2) the
methods used in order to compare the effect of the APAPI
on the reduction of the social inequalities of a return to
work compared with that of the conventional therapy.
Methods/Design
Development of the intervention
The development of our intervention is based at the same
time on 1) the factors identified in the literature having
a positive or a negative influence on the return to work,
2) the results of the previous intervention studies designedto promote the return to work of cancer patients, 3) the
data reported by the « health-employment-information-
services » (SEIS) platform of the Lille CHRU (University
Hospital Centre), designed to prevent the occupational ex-
clusion of current or previous cancer patients.
Factors associated with the return to work
Many factors associated with the return to work have
been identified in the literature. These various factors
can be classified into 3 categories: the individual charac-
teristics, the work-linked factors and the disease or
treatment-linked factors.
As regards the individual characteristics, the studies
highlight in a consensual way that young breast cancer
patients with a higher education level and a high socio-
economic level have a more favourable return-to-work
prognosis [8-11,15,16]. At the psychological level, a per-
son’s propensity to talk about her disease with her col-
leagues, to ask for or to receive help and perceive and
receive social support from her colleagues and superiors
[17,18] and the level of control perceived as high of the
disease and the treatment in the workplace are factors
linked positively with a return to work [19]. Benefiting
from the support of her family and the health profes-
sionals, as well as taking care of her health and imple-
menting coping strategies would also facilitate the return
to work [20].
As regards the work-linked factors, being in full-time
employment at the time of the diagnosis, having a bear-
able workload, manageable job requirements and a cer-
tain job satisfaction appear to be good return-to-work
predictors [8,11,19,21,22]. An adjustment of the working
conditions at the time of the return to work also helps
in bringing the date of this forward [18]. Grunfeld et al.
[23] also identify that positive representations on the part
of the employers concerning the impact of the cancer and
the treatment on the work play a role in this process.
Lastly, as regards the factors linked to the disease and
the treatment in the return to work of breast cancer pa-
tients, Amir and Brocky [12] show that the absence of
pain, fatigue, dyspnea, physical limitations, mental co-
morbidity, a good previous physical level and good health
self-assessment promote the return to work. Furthermore,
not having had chemotherapy during the course of treat-
ment also appears to be a factor promoting the return to
work [11].
Of the aforementioned individual characteristics and
work-linked factors, some reflect a socio-economic pre-
cariousness demonstrating the importance of the social
inequalities of the return to work: thus low incomes, a
greater physical workload and a lower level of education
are factors of social inequalities in the return to work for
cancer patients compared with their more qualified coun-
terparts with a lower physical workload and better incomes
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equalities in rehabilitation programmes for cancer patients.
Thus, the study undertaken by Pauwels et al. [27] shows
that the younger breast cancer patients with low incomes
are, the more they need information and consultations
with a psychologist and this right from the onset of the
treatment compared with older women with better in-
comes. As for Holm et al. [28] they report that women
with a low level of education and low incomes, living on
their own, display a greater need for physical, emotional
and financial support than women with a higher level of
education. The authors recommend moreover paying spe-
cial attention to people from precarious socio-economic
groups, in particular by developing interventions aimed at
offsetting these inequalities.
Results of previous intervention studies
Several reviews of the literature concerning the content
of the job-related intervention studies of cancer patients
have been conducted by various authors in order to
build on the already existing interventions and produce
recommendations regarding methods and practices. The
review of the literature conducted by Hoving and al. [14]
is mainly composed of intervention programmes designed
to improve physical, psychological and social rehabilita-
tion. Of the interventions included for their methodo-
logical qualities, the one performed by Maguire et al. [29]
shows that the group of patients given the benefit of indi-
vidual interviews of the « counselling » type by a nurse
have a higher return-to-work rate (n = 32.76%) than the
control group (n = 25.54%).
According to Verbeek and Spelten [30], interventions
should pay greater attention to and include more infor-
mation, support and counselling about work-related is-
sues not only from the health professionals but also
from the employers. Furthermore, Grunfeld et al. [23]
recommend the setting in place of a dialogue between
employees and employers, as well as adjustments at the
workplace in order to meet the needs of the patients and
thus enable a gradual return to work.
As for Tamminga et al. [3] they put the emphasis on two
main return-to-work prognostic factors: self-assessment of
work ability and the physical workload. They underline the
fact that return-to-work enhancement has rarely been the
main objective of a study. More frequently the content of
the interventions comprises vocational training, encourage-
ment, work-related counselling and work adjustments.
According to Tiedtke et al. [31], meetings with the fam-
ily, social and professional environment delivering infor-
mation about the disease and the treatment would back
up the adjustments set in place for breast cancer patients
and therefore influence the return to work. However, the
communication between the various health professionals
is not necessarily efficient and does not provide optimumreturn-to-work support for the patient [31]. More pre-
cisely, the review of the literature done by Boer et al. [32]
shows that multi-disciplinary interventions have real im-
plications for the improving of the return to work com-
pared with the conventional care model and compared
with the other types of intervention.
Tamminga et al. [33] continuing the intervention study
done by Nieuwenhuijsen et al. [13] using a booklet of
practical advice (« 10 steps of advice ») for the patient and
the occupational physician, propose an intervention study
protocol aimed to improve the patient’s return to work via
a randomized controlled trial. The content of their inter-
vention is composed of 1) 4 meetings with a nurse in
order to start the occupational rehabilitation as early as
possible 2) a meeting with the patient, the occupational
physician and the line manager in order to draw up a
return-to-work plan, and 3) correspondence between the
GP and the occupational physician in order to improve
communication.
The « Health-Employment-Information-Services »
telephone platform
The « Health-Employment-Information-Services » (SEIS)
telephone platform was created in Lille in 2006 given the
demand from patients suffering from cancer or chronic dis-
eases, the return-to-work difficulties, the needs highlighted
by the professionals, the patients’ ignorance of the many
aid facilities in existence and the need to develop local sup-
port. The main purpose of this facility is to prevent the oc-
cupational exclusion of people suffering from all types of
health problems. Nurses trained in listening techniques in-
form and help the callers with all the procedures of a socio-
professional nature. What is involved above all is ensuring
the consistency of the support practices between the vari-
ous health players and anticipating the brakes or the diffi-
culties encountered by the patients with regard to their
return to work. When a person calls the platform, they can
be given information immediately that is tailored to their
situation (pathology, occupational status, health insurance
scheme …). Individual contacts with the networks of oc-
cupational health, job retention and return to work pro-
fessionals are also proposed. An individualised follow-up
through the periodic calling back of the callers up to
6 months after their enquiry is provided. The SEIS nurses
find through their work that both the return to work time
and the return to work conditions could be improved if
certain steps were taken earlier. This backs up what sev-
eral studies demonstrate – that job retention or the return
to work is conditioned by 1) the support from the work
colleagues and superiors for employees, 2) contact be-
tween the patient and their company during the sick leave,
3) the anticipating of the pre-return to work examinations
with the occupational physician (examinations that take
place during the sick leave in order to assess the employee’s
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4) the psychological state of the cancer patients and the
emotional charge built up by the experience of the disease
and the treatment.
To our knowledge no interventions exist that aim more
specifically to reduce the social inequalities of the return
to work. In the light of these different observations, and
taking inspiration from the various results obtained by the
intervention studies on the issue of the return to work, in
particular the recommendations of Tamminga and al. [3],
we have formed the hypothesis that the return to work in
general and the social inequalities in particular could be
positively impacted by the specific support covered by our
intervention.
The particular feature of our intervention is the special
attention given to the reducing of the social inequalities of
the return to work of breast cancer patients; it was there-
fore this aspect that was emphasised in the construction
of our assessment protocol of the effectiveness of this
intervention.
Content of the intervention
These various findings and experiences thus led us to plan
the content of our intervention as follows: 1) 4 interviews
with a psychologist at the hospital, conducted during the
standard course of treatment, on the same day as the con-
ventional follow-up consultation; 2) linked up with a con-
sultation with a specialist return-to-work physician.
Meetings with the psychologist
Four one-hour interviews are scheduled throughout the
course of treatment. These interviews are coupled with
the necessary travel for the dispensing of the care and
therapy, not generating therefore any additional travel
for the patients. These interviews are based on the prob-
lem solving method [34].
The first interview is conducted at the start of the treat-
ment, on the same day as the first chemotherapy session.
Its purpose, through a semi-directive interview, is to iden-
tify the repercussions of the disease and the treatment on
the patient’s job situation, clarify her needs and her expec-
tations with regard to her job, and her wishes and difficul-
ties with regard to this situation.
The second interview is conducted on the same day as
the 6th chemotherapy session. Its aim is to help the pa-
tient clarify the gap between the actual situation and the
desired situation thanks to problem analysing techniques.
The situations to be overcome are analysed with precision,
as are the brakes and the resources thanks to an analysis
of the psychological tests that the patient will have under-
gone during the pre-test (detailed below). This interven-
tion positions these psychosocial tests both at the level
of the overall assessment of the research project and at
the level of the intervention itself as a tool helping thepatients to become aware of their resources, difficulties and
changes over the course of time. With the patient’s agree-
ment, an area for work resulting from the questionnaires is
chosen (social support, coping, attitude with regard to
problems). The SEIS platform is presented as a practical
tool that can be mobilised during this interview in order to
anticipate the return-to-work strategies as early as possible.
The third interview is conducted during the final chemo-
therapy session. It invites the patient to invent new
strategies for reducing the difficulties identified via
problem-solving techniques. The psychologist helps the
patient to develop her psychosocial skills, test out new be-
haviours and call upon the external resources available
such as the SEIS platform in order to promote the return
to work. Depending upon the problem to be solved, pa-
tients may be offered relaxation techniques, role playing,
or contacts with local professionals.
Between the 3rd and the 4th interview, the patient is in-
vited to choose new strategies she feels capable of imple-
menting in order to test them out in a real situation. This
step corresponds to the implementation of an action plan.
Finally, the fourth interview is conducted 3 months after
the completion of the radiotherapy, at the same time as a
post-radiotherapy follow-up consultation. Its purpose is to
examine one by one the adaptation strategies that have
been tested between sessions 3 and 4 in order to deter-
mine their advantages and drawbacks, the results obtained
and the emotions felt. It is a question of strengthening the
feeling of self-efficacy thanks to the objectives attained,
pursuing the problem-solving learning process with the
objectives that have not been attained, generalising the
new effective adaptation strategies and rethinking the inef-
fective adaptation strategies.
Meeting with the job retention specialist physician
Support from the psychologist is complemented, follow-
ing the final interview, with a job retention/return to
work consultation with a physician specialising in the re-
turn to work. To this end the patient is asked to come
with her latest medical results to a medical consultation
at the usual treatment site. The return-to-work specialist
then drafts a summary, using as a basis to work from
the medical file and the psychosocial support assess-
ment, together with recommendations for a return-to-
work plan. This summary is forwarded, via the patient,
to her company’s occupational physician and her GP. The
aim of this consultation is thus to facilitate the communi-
cation between the various players involved in the return
to work of the patient and promote a multi-disciplinary
analysis of the patient’s needs and expectations.
Intervention assessment methods
In order to assess the effect of this early active individua-
lised psychosocial support (APAPI) compared with the
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equalities of the return to work at 12 months, we set in
place a comparative, randomised, prospective and multi-
centre intervention study.
The secondary objectives were to assess the effect of
this APAPI compared with the conventional treatment
on the quality of the return to work at 18 and 24 months,
and on the individual and collective resources of the pa-
tients such as the perceived social support, the coping
strategies, the attitude to problems, anxiety and depres-
sion, the quality of life and the contacts with the SEIS
platform. Lastly, a cost analysis of the benefit of this ac-
tion is also planned.
The Committee of Protect People NORTHWEST III gave
a favorable opinion for the study APAPI the September 8,
2012. The CPP reference for this study is: 2012-13.Participants
In order to carry out this study we opted for the popula-
tion of women aged between 18 and 55 years with a uni-
lateral breast cancer with local extension having been
given surgery followed by adjuvant chemotherapy, with or
without radiotherapy, in employment (salaried employees,
trades people and the professions) at the time of the diag-
nosis and dealt with by one of the 2 investigating centres.
The criteria for non-inclusion are the presence of in
situ lesions, cancer relapse, a metastatic cancer at the out-
set, a bilateral location. The patients with physical, psy-
chic, psychiatric or cognitive disabilities preventing them
from replying to the questionnaires and taking part in the
interviews, and people having received prior treatment for
a serious illness lasting at least 6 months (owing to an-
other pathology) and people under wardship or guardian-
ship are also not included in this study.Recruitment and investigating sites
In order to have the most representative population pos-
sible, the recruitment and the intervention are performed
at two investigating centres in Nord-Pas-de-Calais, the
Lille Centre Régional de Lutte contre le Cancer (Centre
Oscar Lambret) and the Douai Centre d’Imagerie et de
Cancérologie (Centre Léonard de Vinci).
The Centre Oscar Lambret is a Private Health Establish-
ment of Collective Interest highly specialised in cancer re-
search. It is associated with the Lille University Hospital
Centre (CHRU) and is part of the group of Cancer
Centres within the French Federation of Cancer Centres.
By belonging to this group, the Centre Oscar Lambret
provides an additional guarantee of quality and effective-
ness to its cancer treatment, teaching and research actions
at the service of the patient. The centre deals with 1,800
to 1,900 breast cancer patients per annum, i.e. 30 to 35%
of the cases in the region.The Centre d’imagerie et de cancérologie Léonard de
Vinci is a private establishment associated with a medical
group comprising radiology, radiotherapy, scanner and
MRI centres.
The centre treats 1200 to 1300 new cancer cases every
year (all locations taken together).
Care and randomisation of patients
The standard care for breast cancer patients at each site
is the same: following the cancer diagnosis, the medical
files of the patients are examined at a multidisciplinary
coordination meeting the purpose of which is to decide
on the course of treatment to be given. Within a time-
scale of 1 to 2 weeks from the diagnosis, the patients are
seen by an oncologist who explains to them what their
course of medical treatment will consist of and whether
or not this will involve chemotherapy. An appointment
is then made for the following week with a nurse for a
pre-chemotherapy consultation. During this interview
lasting approximately 90 minutes, the nurse reviews with
the patient what she has understood about the diagnosis
and the treatment and her concerns and needs. The nurse
can direct the patient to other professionals (psychologist,
dietician, physiotherapist, welfare worker). The first chemo-
therapy session takes place approximately 1 month after
this consultation.
The study is therefore proposed by the medical oncolo-
gist during the first care consultation to the patients fulfill-
ing the inclusion criteria in the 2 investigating centres.
After having explained the study to the patients with the
information leaflet, those who accept sign a consent form.
Next the patients will be randomised into two groups:
1) Group A: the « intervention » group which will have the
benefit of the early active individualised psychosocial sup-
port in addition to the usual care. 2) Group B: the «stand-
ard care » group hereafter referred to as the “control
group” which will follow the regular course of treatment
without having the benefit of the psychosocial support as
described above. This standard care already includes tools
for identifying situations of great social distress enabling
the patients to be directed to the regular social helpers.
Just after the inclusion, and before the start of their
chemotherapy treatment, both groups of patients undergo
the same battery of tests (pre-test).
They are then invited to do the same battery of tests
and fill in the questionnaires again by letter 12 months
after the start of their chemotherapy treatment. Follow-
up of the return to work in terms of the rate and the
conditions and a follow-up of the quality of life are
also done at 18 and 24 months. In the event of their
failure to reply to the questionnaires, the patients are
re-contacted twice by telephone within the space of
15 days following the sending out of the questionnaires
(Figure 1).
Figure 1 Study design.
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During the pre- and post-tests (on the inclusion and
12 months after the diagnosis), for the two groups (A «
intervention » and B « control »), we use a battery of tests
with a questionnaire and validated psychological tests.
The questionnaire covers the socio-demographic char-
acteristics of the patients, their disease (objective and
subjective criteria such as fatigue, anxiety, mood disor-
ders…), changes in their socio-professional situation dur-
ing the study, as well as the difficulties they encounter
with regard to the repercussions of their cancer on their
situation (sick leave, financial aid, employment, recogni-
tion of disability, psychological aid, paramedical assist-
ance and guidance). Social fragility is estimated using
the Epices score [35], which will enable the women who
are the most fragile socially speaking (FS+) to be distin-
guished from those who are less fragile socially (FS-)
through a cut-off at the median. The Epices score was in
fact built on a questionnaire comprising the various di-
mensions of precariousness: nationality, level of educa-
tion, occupation, composition of household, housing,
social protection, perceived health, income, leisure ac-
tivities, financial difficulties, social integration, seeking
healthcare, serious events experienced before the age of
18 years.
The measurement of the social support is done by the
QSSP [36], the coping strategies of the patient by the
WCC [37], the attitude to problems by the QAP [38],
anxiety and depression by the HADS scale [39] and the
quality of life by the FACT-G [40]. The quality of the re-
turn to work is estimated by the assessment of the work
ability (WAI) [41].Sample size
The number of patients was defined according to the ex-
pected reduction in the social inequalities of the return-
to-work rate.
The research done by Quinton-Fantoni et al. [9] showed
that the return-to-work rate 12 months after the diagnosis
of women having had chemotherapy was 50% on average,
but there was a difference of 22% between the most pre-
carious and the least precarious cases.
The recruitment of 125 patients per group (A « inter-
vention » and B « control »), with the acceptance of a
first order risk of 5% and a power of 80%, would enable
a reduction in the gap between the precarious cases and
the non-precarious cases of 13.5 points to be demon-
strated, enabling the difference in the return-to-work
rate to be lowered from 22% to 8.5%. In order to make
allowance for possible drop-outs during the study and
unusable data, the minimum number of patients to
be recruited was increased by 20%. The final number
therefore comes to 150 women per group, i.e. a total
of 300 patients.Data management
A dedicated database was created for the study which was
tested out and validated before any data was entered. This
dedicated database will be developed with the aid of
Capture System (CLINSIGHT), which is a software pack-
age designed for the global management of clinical studies
and meeting the study’s regulatory requirements. A data
validation plan will be drawn up and will describe in detail
the checks to be performed for each variable together
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authorised.
The observation books will be checked when they are
collected and then the data will be entered followed by
post-checking (data entered/hard copy data). This data
will be checked once again by the team in charge of the
data management via the error messages received from
the validation programmes. Blatant errors will be cor-
rected. The other errors, omissions or inconsistencies will
be mentioned on correction request forms that will be
sent to the investigating physician and the corrections in-
cluded in the database.
The database will be frozen after the final quality con-
trol then exported to the SPSS statistical software as per
an automated and validated procedure.The participants
In the context of the study, two psychologists are respon-
sible for doing the APAPI, each one reporting to an investi-
gating site. In order to provide similar support from a
theoretical and practical standpoint, and in accordance with
the recommendations of Tamminga et al. [3] who stress the
importance of individual intervention with a cognitive be-
havioural component, both the psychologists received prior
training in cognitive behavioural therapy and work with an
interview template specific to each meeting with the partici-
pants. Regular meetings will be held in order to harmonise
their practices during the support provided.
The occupational physician of the occupational diseases
and job retention unit of the Lille CHRU, a return-to-work
specialist, is responsible for receiving each participant of
the study following the 4 interviews with the psychologists.
These consultations take place at the hospital department
administering the standard care.Results expected
This is a multi-disciplinary project through which we hope
the APAPI will enable a reduction in the social inequalities
of the return to work (timescale, conditions, job retention
rate) of the breast cancer patients compared with those
who do not have the benefit of the APAPI.
The main observation we expect to make is that the
social inequalities of the return-to-work rate 12 months
after the diagnosis of the breast cancer patients are less
for the APAPI group than for the control group.
We also expect to observe that this reduction in the
inequalities in the intervention group compared with the
control group also concerns the conditions and the return
to work at 12, 18 and 24 months after the diagnosis, the
psycho-social factors studied and worked on with the pa-
tients, that quality of life of the patients at 12, 18 and
24 months and the proportion of people having made use
of the SEIS platform.Another result expected is the overall improvement in
all these factors in the intervention group compared
with the control group.
Statistical analyses
The data will be entered twice then exploited in SAS
V9.2 and SPSS v20. After the quality of the data has
been checked and any corrections made, a description of
the population included in the study will be given. A
comparison of the main return-to-work criteria of the
two groups drawn at random will be done (age, stage of
development of the disease, occupational category).
The reduction in the social inequalities of the return
to work will be studied by comparing the deltas (difference
in the return-to-work rates between the two sub-groups
FS + and FS-) between the control group « B » and the
intervention group« A » having the benefit of the APAPI.
A rough comparison of the two deltas will be done with a
Chi2 test. The taking into account of adjustment factors
(age, secondary effects of the treatment …) will be done
with the aid of multivariate regression models.
As regards the secondary objectives, what is involved
here is comparing for the 2 groups:
1) the deltas of the quality of the return to work at 18
and 24 months after the diagnosis (WAI and job reten-
tion rate); 2) the deltas of the psychosocial characteris-
tics (QSSP, WCC, QAP, HADS and FACT-G scores) and
the external resources (number of contacts with the SEIS
platform) at 12 months from the diagnosis.
Medico-economic analyses
From the standpoint of the cost-benefit analysis, the
APAPI support action protocol will be useful to imple-
ment compared with the conventional support action if
the additional benefits are greater than the additional
costs.
The point of departure for the analysis is situated in the
identification of the mean marginal effect (in the popula-
tion treated) of the support action on the probability of
regaining employment after a certain fixed period of time
(or over the time actually required itself ). This effect is
measured by the statistical model and provides the
weighting for the various costs and benefits linked to this
action.
The social security schemes and the company employ-
ing the person are the main beneficiaries of the early re-
turn to work through the number of days of sick leave
saved and the rise in productivity due to the return to
work of a person in theory better qualified than her re-
placement. On the markets where there is unemploy-
ment, the benefit will have to be reduced by the amount
of the unemployment benefit paid to the replacement.
The monetary costs result mainly from the additional
expenses incurred by the APAPI measure. They include
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ing teams; it is then a question of calculating the net
additional cost. It is however necessary to take into ac-
count the opportunity costs of the staff used for the
intervention as they would be employed in other tasks if
they were not involved in the APAPI measure. The mon-
etary costs also include the fixed operating costs (facil-
ities, equipment, expenses, etc.) and the cost of the
increase in the activity of the SEIS platform.
Ultimately, several scenarios will be envisaged depend-
ing upon the elements that it is decided to include in
the costs and benefits: various situations will be tested
out to give a broad range of possibilities for the public
decision-makers when making their assessment of the
APAPI measure.
Discussion
The originality of our study resides in the specific nature
of our intervention. In point of fact, few interventions
aim to reduce the social inequalities of the return to
work of breast cancer patients.
Consistently with the previous research [3,27] our
protocol is included in the existing course of treatment
as early as possible so as not to make the patient support
too unwieldy. The meetings with the psychologist there-
fore take place where the standard care is administered.
Next, the inclusion of the SEIS platform enables inter-
active and personalised support to be offered to the par-
ticipants that is directly linked to their work-related
questions, which is different from most of the studies
which supply an educational leaflet [13,33]. Lastly, in our
intervention, the meetings are conducted by psychologists
trained in cognitive behavioural therapies, enabling the
psychosocial skills of the participants to be developed that
relate to the problem solving techniques.
At the methods level, the purpose of our study is to
develop an intervention that is assessed in the context of
a randomised controlled trial, which constitutes the first
strong point of our research. We have in fact taken into
account the recommendations resulting from the previous
studies deemed sometimes as weak from the methods
standpoint, in particular because of the absence of a con-
trol group. The second strong point of the study resides in
the participation of two of the region’s investigating cen-
tres in order to increase the heterogeneousness of the
population studied. In point of fact each investigating site
uses different socio-demographic and economic criteria
for the investigation of its population. The Centre Oscar
Lambret, located in the heart of the Lille metropolitan
area, deals rather with patients from the tertiary sector,
whereas the Centre Léonard de Vinci in Douai, which
is located rather in an industrial and rural area, deals
with the patients from primary and secondary sectors.
Randomisation is therefore done independently at eachinvestigating site in order to best preserve the socio-
demographic criteria that will enable the social inequalities
of the return to work to be observed.
The third strong point concerns the recruitment of the
participants. In order to limit the biases, we chose to se-
lect women aged between 18 and 55 years; in point of
fact beyond the age of 55 the French social security system
proposes specific care packages enabling patients close to
the retiring age not to return to work. In the light of the
results of the literature on the impact of chemotherapy on
the return-to-work time [11], we also opted to exclude
any patient not given adjuvant chemotherapy.
In theory our study is likely to be inherently limited by
the very construction of the protocol. In point of fact,
given that the two investigating sites are located in the
same region, there is a limit on the generalising of the
results of the efficacy of this protocol at the national and
even international level. What is more, APAPI is based
on the SEIS platform which is not a standardised service
in France. Thus the setting in place as it is of this inter-
vention in other regions would require alternatives in
terms of interactive individualised support equivalent to
the SEIS platform. Moreover, in the light of the statistics,
Nord-Pas-de-Calais is one of the regions in France most
affected by cancer and unemployment. So, if the inter-
vention successfully impacts the social inequalities of
the return to work in our region, we consider we are
justified in thinking that a similar scheme to APAPI
would also act on these inequalities in other regions,
provided the planned organisation is kept to: conduct-
ing of the interviews with the psychologist not requiring
any additional travel on the part of the patients, con-
ducting of the interviews with the physician specialising
in job retention at the site where the patients are
treated, communication by letter between the physician
specialising in job retention, the GP and the occupa-
tional physician.
Clinical prospects
The data collated from the A « intervention » and B «
control » groups will enable the difficulties and socio-
professional inequalities usually encountered by breast
cancer patients to be identified, as well as the medical,
social, psychological and economic determinants.
The identification of the psycho-socio-economic deter-
minants as return-to-work factors would enable opti-
misation of the support for breast cancer patients. The
generalising of support practices on the basis of the rele-
vant factors holds out the prospect of a positive economic
impact and above all better return-to-work conditions for
the people having been treated for cancer with the aim of
maintaining an acceptable quality of life for them, creating
a dynamic and positive repercussions on everything that
may have been affected by the cancer and its treatment
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social skills).
The aim of this support being to take into account and
modify certain factors of psychosocial fragility (poor per-
ceived social support, little in the way of developed cop-
ing strategies, attitude to negative problems), we expect
to observe a benefit for all the patients but a greater one
for those in a situation of social fragility.
We hope to test out an original intervention that of-
fers, not the same thing for everyone, but more for those
who are in greater need than the others, so as to reduce
the dual and even triple distress when the sick person is in
a situation of social, psychological and/or occupational
fragility.
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